Home/Filings/4/0001213900-23-089579
4//SEC Filing

WIGGANS THOMAS G 4

Accession 0001213900-23-089579

CIK 0001788028other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:06 PM ET

Size

5.0 KB

Accession

0001213900-23-089579

Insider Transaction Report

Form 4
Period: 2023-11-21
Transactions
  • Purchase

    Voting Common Stock

    2023-11-21$0.64/sh+10,000$6,38340,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 to $0.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001208907

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:06 PM ET
Size
5.0 KB